Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Americans want to see a bipartisan fix for Obamacare: Reuters/Ipsos poll

As Republican and Democratic lawmakers clash over the future of Obamacare, Americans largely are eager for a bipartisan solution to its shortcomings, according to a Reuters/Ipsos opinion poll.

Read More »

Neos Therapeutics Jumps After PDL BioPharma Makes an All-Cash Take Out Offer

Shares of Neos Therapeutics soared more than 38 percent after PDL BioPharma announced its intention to acquire the company in an all-cash deal that could total about $287 million.

Read More »

High cholesterol levels among U.S. adults declining: CDC report

The prevalence of U.S. adults with high cholesterol declined significantly between 1999-2000 and 2015-2016, achieving a long-term public health goal, according to data released by the Centers for Disease Control and Prevention’s National Center for Health Statistics.

Read More »

Medical Advertising Hall of Fame names Robert Leverte 2018 Inductee

The membership of the Medical Advertising Hall of Fame elected Robert Leverte as its 2018 inductee. Leverte’s career included founding ERS – an in-house ad agency at ER Squibb – co-founding Ruvane-Leverte advertising, Chairman at Bozell Jacobs Medical Group and CEO of the Leverte Companies.

Read More »

Ablynx Banks $200M IPO in Nasdaq Debut

Ghent, Belgium-based Ablynx NV announced the price of its U.S. initial public offering (IPO) at $17.50.

Read More »

MacroGenics, Incyte Score $900M R&D Deal

Icyte Corporation struck a deal worth up to $900 million with Maryland-based MacroGenics Inc. for that company’s investigational PD-1 inhibitor.

Read More »

U.S. committee recommends GSK shingles vaccine over Merck rival

The committee responsible for U.S. vaccination schedules gave a preferential recommendation to GlaxoSmithKline’s newly approved shingles vaccine Shingrix over Merck’s established product Zostavax.

Read More »

GSK ready to build drug testing in EU as Brexit looms

Britain’s biggest drugmaker GlaxoSmithKline is moving ahead with Brexit contingency planning “right now,” including preparing a system to test drugs in the European Union if Britain crashes out of the bloc without a trade deal.

Read More »

U.S. lawmakers will not tackle healthcare this year, Ryan says: Reuters interview

Republican lawmakers will not take up a bipartisan plan to stabilize Obamacare insurance markets or try again to repeal and replace the law during 2017 House of Representatives Speaker Paul Ryan said, signaling his party was shelving the matter until the 2018 U.S. congressional election year.

Read More »

Baxter expects $70 million hit to fourth-quarter 2017 sales from Hurricane Maria

U.S. hospital products maker Baxter International Inc. forecast a nearly $70 million hit to its fourth-quarter 2017 revenue, due to manufacturing disruptions arising from Hurricane Maria.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2018 Focus: Top 50 Pharma, Company of the Year and more!


Ad Right Bottom